PACIFIC EDGE LIMITED
ASX:PEBPharmaceuticals, Biotechnology & Life SciencesShare count grew 52% in 24 months; 2 cash raises in 24 months; options/rights overhang 7% of shares
PACIFIC EDGE LIMITED's ordinary share count was 1.23B as of June 2026, up 52.1% since July 2024. The company raised capital twice in the past 24 months for total proceeds of A$56.8M, most recently a A$36.1M placement in May 2026. Options and rights on issue could convert into 86M new shares, equal to 6.9% of the current share count, with 0% in the money at the current share price. The company does not have a current quarterly cash report on record, so no quarterly cash balance or funding-runway figure is disclosed. No proposed securities issues (Appendix 3B) are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 8 July 2026 | 3G · unquoted | PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 1.24B | Appendix 3G |
| 4 June 2026 | 2A · quoted issue | PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 1.18B | Appendix 2A |
| 4 June 2026 | 2A · quoted issue | PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 1.23B | Appendix 2A |
| 4 June 2026 | 2A · quoted issue | PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 1.17B | Appendix 2A |
| 15 May 2026 | 2A · quoted issue | PEB : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 1.17B | Appendix 2A |
Capital raises
2 cash raises in the last 24 months · 1 in the last 12 months
Pending proposed issues
Options & convertible securities
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.